| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 26 | 2025 | 573 | 6.130 |
Why?
|
| RNA | 12 | 2024 | 570 | 1.750 |
Why?
|
| Immunoprecipitation | 8 | 2022 | 198 | 1.740 |
Why?
|
| Binding Sites | 14 | 2022 | 1304 | 1.330 |
Why?
|
| Caenorhabditis elegans | 5 | 2016 | 223 | 1.260 |
Why?
|
| Transcriptome | 7 | 2024 | 955 | 1.110 |
Why?
|
| Gene Library | 2 | 2017 | 217 | 1.020 |
Why?
|
| Gene Expression Profiling | 10 | 2020 | 1711 | 0.980 |
Why?
|
| RNA, Ribosomal | 3 | 2025 | 63 | 0.970 |
Why?
|
| RNA, Small Nucleolar | 1 | 2025 | 13 | 0.950 |
Why?
|
| Sequence Analysis, RNA | 6 | 2019 | 369 | 0.860 |
Why?
|
| Computational Biology | 6 | 2019 | 810 | 0.810 |
Why?
|
| Cross-Linking Reagents | 3 | 2017 | 55 | 0.780 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2020 | 80 | 0.780 |
Why?
|
| Caenorhabditis elegans Proteins | 5 | 2016 | 88 | 0.720 |
Why?
|
| Chromatin | 5 | 2020 | 554 | 0.710 |
Why?
|
| RNA Splicing | 8 | 2024 | 226 | 0.700 |
Why?
|
| Gene Regulatory Networks | 3 | 2013 | 351 | 0.680 |
Why?
|
| Alternative Splicing | 8 | 2023 | 352 | 0.660 |
Why?
|
| Protein Binding | 12 | 2024 | 1756 | 0.640 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2022 | 880 | 0.580 |
Why?
|
| Reverse Transcription | 1 | 2017 | 4 | 0.570 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 2522 | 0.550 |
Why?
|
| DNA | 3 | 2024 | 1609 | 0.540 |
Why?
|
| CRISPR-Cas Systems | 3 | 2021 | 254 | 0.520 |
Why?
|
| Staining and Labeling | 1 | 2016 | 187 | 0.510 |
Why?
|
| K562 Cells | 5 | 2020 | 95 | 0.510 |
Why?
|
| RNA, Messenger | 9 | 2024 | 2820 | 0.500 |
Why?
|
| Introns | 4 | 2024 | 300 | 0.470 |
Why?
|
| Genome, Helminth | 2 | 2011 | 10 | 0.470 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 1265 | 0.460 |
Why?
|
| Spliceosomes | 3 | 2025 | 53 | 0.430 |
Why?
|
| Base Sequence | 8 | 2020 | 3103 | 0.430 |
Why?
|
| Hep G2 Cells | 5 | 2023 | 85 | 0.420 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 548 | 0.410 |
Why?
|
| RNA, Double-Stranded | 2 | 2024 | 63 | 0.400 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2024 | 537 | 0.390 |
Why?
|
| Databases, Genetic | 3 | 2020 | 474 | 0.390 |
Why?
|
| Molecular Sequence Annotation | 3 | 2020 | 149 | 0.370 |
Why?
|
| Adenosine Deaminase | 3 | 2021 | 89 | 0.370 |
Why?
|
| Longevity | 1 | 2013 | 135 | 0.370 |
Why?
|
| RNA, Small Nuclear | 2 | 2025 | 47 | 0.370 |
Why?
|
| RNA Editing | 3 | 2021 | 34 | 0.350 |
Why?
|
| Animals | 22 | 2025 | 34241 | 0.310 |
Why?
|
| Transcription Factors | 4 | 2013 | 2593 | 0.310 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 359 | 0.290 |
Why?
|
| Humans | 37 | 2025 | 125392 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1005 | 0.270 |
Why?
|
| Cell Line | 4 | 2020 | 2756 | 0.270 |
Why?
|
| Protein Isoforms | 2 | 2018 | 403 | 0.240 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2024 | 20 | 0.230 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group M | 1 | 2024 | 3 | 0.230 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2024 | 32 | 0.230 |
Why?
|
| Aging | 4 | 2016 | 1182 | 0.220 |
Why?
|
| RNA Polymerase II | 1 | 2024 | 100 | 0.220 |
Why?
|
| RNA Splice Sites | 3 | 2024 | 88 | 0.220 |
Why?
|
| HEK293 Cells | 4 | 2024 | 733 | 0.220 |
Why?
|
| 3' Untranslated Regions | 4 | 2019 | 163 | 0.220 |
Why?
|
| Mice | 13 | 2025 | 17637 | 0.220 |
Why?
|
| Nucleic Acid Conformation | 3 | 2024 | 181 | 0.210 |
Why?
|
| Organ Specificity | 3 | 2013 | 428 | 0.210 |
Why?
|
| Nucleotide Motifs | 4 | 2018 | 43 | 0.210 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2023 | 44 | 0.200 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2020 | 64 | 0.200 |
Why?
|
| Exons | 5 | 2024 | 798 | 0.200 |
Why?
|
| Optical Imaging | 1 | 2023 | 67 | 0.200 |
Why?
|
| Genomics | 3 | 2020 | 1499 | 0.190 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2021 | 1 | 0.190 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2020 | 161 | 0.190 |
Why?
|
| Interferon Type I | 1 | 2021 | 107 | 0.180 |
Why?
|
| MicroRNAs | 2 | 2022 | 837 | 0.180 |
Why?
|
| Genome | 2 | 2020 | 470 | 0.180 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2020 | 12 | 0.180 |
Why?
|
| Intracellular Space | 1 | 2020 | 49 | 0.170 |
Why?
|
| Blast Crisis | 1 | 2020 | 17 | 0.170 |
Why?
|
| Retroelements | 1 | 2020 | 40 | 0.170 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 137 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2023 | 724 | 0.170 |
Why?
|
| Antibodies | 2 | 2023 | 374 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2019 | 1502 | 0.170 |
Why?
|
| Substrate Specificity | 1 | 2020 | 295 | 0.160 |
Why?
|
| Ribosome Subunits, Small | 1 | 2019 | 3 | 0.160 |
Why?
|
| RNA Precursors | 2 | 2019 | 67 | 0.160 |
Why?
|
| Ribosomal Proteins | 1 | 2019 | 71 | 0.160 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 161 | 0.160 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2020 | 369 | 0.160 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 348 | 0.150 |
Why?
|
| Ribosomes | 1 | 2019 | 137 | 0.150 |
Why?
|
| Metformin | 1 | 2020 | 151 | 0.150 |
Why?
|
| RNA Stability | 2 | 2016 | 84 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 151 | 0.150 |
Why?
|
| RNA Recognition Motif Proteins | 1 | 2018 | 16 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2022 | 813 | 0.150 |
Why?
|
| Glioma | 1 | 2023 | 492 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2023 | 1186 | 0.140 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2017 | 55 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 398 | 0.140 |
Why?
|
| Conserved Sequence | 3 | 2010 | 291 | 0.140 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 96 | 0.140 |
Why?
|
| Cell Survival | 2 | 2016 | 814 | 0.140 |
Why?
|
| Alu Elements | 3 | 2024 | 65 | 0.140 |
Why?
|
| Transcription, Genetic | 5 | 2024 | 1699 | 0.140 |
Why?
|
| Exonucleases | 1 | 2017 | 23 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2017 | 79 | 0.140 |
Why?
|
| Cluster Analysis | 3 | 2013 | 398 | 0.140 |
Why?
|
| Alleles | 2 | 2019 | 1615 | 0.140 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2016 | 9 | 0.130 |
Why?
|
| Software | 2 | 2018 | 684 | 0.130 |
Why?
|
| Endonucleases | 1 | 2016 | 54 | 0.130 |
Why?
|
| Protein Domains | 1 | 2017 | 236 | 0.130 |
Why?
|
| Homologous Recombination | 1 | 2016 | 92 | 0.130 |
Why?
|
| GATA Transcription Factors | 1 | 2016 | 7 | 0.130 |
Why?
|
| Photochemical Processes | 1 | 2016 | 6 | 0.130 |
Why?
|
| RNA Interference | 2 | 2020 | 502 | 0.130 |
Why?
|
| Cerebellar Diseases | 1 | 2017 | 73 | 0.130 |
Why?
|
| RNA-Binding Motifs | 1 | 2016 | 3 | 0.130 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 13 | 0.130 |
Why?
|
| Mutation | 4 | 2017 | 5849 | 0.130 |
Why?
|
| Motor Neurons | 1 | 2016 | 138 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 54 | 0.120 |
Why?
|
| Datasets as Topic | 1 | 2016 | 89 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2016 | 69 | 0.120 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 73 | 0.120 |
Why?
|
| Protein Transport | 1 | 2016 | 368 | 0.120 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 897 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2016 | 203 | 0.120 |
Why?
|
| Autistic Disorder | 1 | 2018 | 351 | 0.120 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 149 | 0.120 |
Why?
|
| Fibroblasts | 2 | 2016 | 888 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 333 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2020 | 837 | 0.120 |
Why?
|
| DNA Repair | 1 | 2017 | 585 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 1897 | 0.110 |
Why?
|
| Genome, Human | 2 | 2020 | 1273 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 1113 | 0.110 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2013 | 25 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2016 | 834 | 0.110 |
Why?
|
| Registries | 1 | 2020 | 1435 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 221 | 0.110 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2013 | 9 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2015 | 459 | 0.110 |
Why?
|
| Peptides | 1 | 2016 | 811 | 0.100 |
Why?
|
| DiGeorge Syndrome | 1 | 2013 | 80 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 1586 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 236 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 3350 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1080 | 0.100 |
Why?
|
| Peptide Hormones | 1 | 2013 | 68 | 0.100 |
Why?
|
| Systems Biology | 1 | 2011 | 57 | 0.090 |
Why?
|
| Algorithms | 2 | 2016 | 1630 | 0.090 |
Why?
|
| Apoptosis | 1 | 2017 | 1806 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 354 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 651 | 0.090 |
Why?
|
| Chromosomes | 1 | 2010 | 198 | 0.080 |
Why?
|
| RNA Splicing Factors | 2 | 2023 | 49 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 541 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2020 | 4536 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 778 | 0.070 |
Why?
|
| Evolution, Molecular | 2 | 2010 | 666 | 0.070 |
Why?
|
| Cytoplasm | 2 | 2020 | 296 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 724 | 0.070 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2007 | 16 | 0.070 |
Why?
|
| Brain | 1 | 2018 | 3004 | 0.070 |
Why?
|
| Gene Expression | 3 | 2016 | 1560 | 0.070 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2006 | 5 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 429 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 236 | 0.060 |
Why?
|
| HCT116 Cells | 1 | 2024 | 55 | 0.060 |
Why?
|
| DNA, Superhelical | 1 | 2024 | 20 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2024 | 63 | 0.060 |
Why?
|
| Phenotype | 1 | 2013 | 4263 | 0.060 |
Why?
|
| Interferons | 1 | 2024 | 126 | 0.050 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2023 | 8 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2023 | 88 | 0.050 |
Why?
|
| Histones | 2 | 2020 | 526 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2024 | 216 | 0.050 |
Why?
|
| Neoplasms | 1 | 2017 | 2792 | 0.050 |
Why?
|
| Cell Self Renewal | 1 | 2022 | 43 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2021 | 23 | 0.050 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 13 | 0.050 |
Why?
|
| Cytosol | 1 | 2021 | 162 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2023 | 806 | 0.040 |
Why?
|
| Inflammation | 2 | 2020 | 1446 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 222 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 2020 | 14 | 0.040 |
Why?
|
| Deoxyribonuclease I | 1 | 2020 | 49 | 0.040 |
Why?
|
| DNA Replication Timing | 1 | 2020 | 11 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 149 | 0.040 |
Why?
|
| Metabolism | 1 | 2020 | 42 | 0.040 |
Why?
|
| Transposases | 1 | 2020 | 40 | 0.040 |
Why?
|
| Protein Aggregates | 1 | 2020 | 30 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 123 | 0.040 |
Why?
|
| Male | 3 | 2020 | 61663 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 204 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 166 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 618 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2020 | 570 | 0.040 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2019 | 2 | 0.040 |
Why?
|
| Inosine | 1 | 2019 | 11 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 376 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 63 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 200 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2019 | 63 | 0.040 |
Why?
|
| Autoantigens | 1 | 2019 | 118 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2018 | 124 | 0.040 |
Why?
|
| Adenosine | 1 | 2019 | 127 | 0.040 |
Why?
|
| Disease | 1 | 2019 | 129 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 287 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 251 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2017 | 7 | 0.030 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 2016 | 1 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 581 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2016 | 46 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 444 | 0.030 |
Why?
|
| Transfection | 1 | 2019 | 1069 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 1631 | 0.030 |
Why?
|
| Female | 2 | 2020 | 66885 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 656 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2016 | 119 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 193 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2016 | 55 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 140 | 0.030 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2016 | 19 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 653 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 459 | 0.030 |
Why?
|
| Integrins | 1 | 2016 | 99 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 173 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 4406 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 343 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 259 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2019 | 798 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2017 | 418 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2397 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2016 | 194 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2568 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 379 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 249 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 676 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1007 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 663 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1527 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2016 | 426 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 421 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 818 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2015 | 505 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 1026 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 685 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2894 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 779 | 0.020 |
Why?
|
| Intestines | 1 | 2016 | 577 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2010 | 8 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 769 | 0.020 |
Why?
|
| Genes, Helminth | 1 | 2010 | 22 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1078 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 535 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1271 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1318 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 113 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2640 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4396 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3306 | 0.020 |
Why?
|
| Neurons | 1 | 2018 | 1932 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 3160 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 760 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 79 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2005 | 223 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 1461 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 3056 | 0.010 |
Why?
|